Genovis AB

Genovis AB Series B
Stock Exchange First North Sweden
EPS
SEK0.1
Market Cap
SEK371.03 M
Shares Outstanding
63.1 M
Public Float
-

Profile

Address
Scheelevägen 2
Lund SN 220 07
Sweden
Employees -
Website http://www.genovis.com
Updated 09/14/2018
Genovis AB engages in the development and market of nanotechnology. It develops, produces and markets technologies that facilitate and enable development of new treatment methods and diagnostics for customers in the medical device and pharmaceutical industries. The company was founded by Inga Sarah Maria Fredriksson in 1999 and is headquartered in Lund, Sweden.

Financials

View All
Created with Highcharts 5.0.14Genovis AB Series BNet Income. Fiscal year is January-December. All values SEK Thousands.15 85215 85222 04822 04819 90519 90515 03115 0317 9487 9482013201420152016201705k10k15k20k25k
Created with Highcharts 5.0.14Genovis AB Series BSales/Revenue. Fiscal year is January-December. All values SEK Thousands.8 9128 9128 2528 25213 26813 26818 54118 54122 86722 8672013201420152016201705k10k15k20k25k

Mårten Winge
Chairman
Lena Carina Söderström
Director